NVO Novo Nordisk A/S

Novo Nordisk A/S
Company
Patents are sorted by USPTO publication date, most recent first
APP
Utility
An Injection Device With Needle Cleaning
19 Nov 20
The invention relates to a medical injection device having a needle cannula for multiple use and which needle cannula is cleaned between subsequent injections.
Simon Munch Pedersen, Bo Radmer
Filed: 19 Nov 18
APP
Utility
Drug Injection Device with Deflectable Transducer
19 Nov 20
The present invention provides a drug injection device (100, 100′, 100″) comprising a first element (130) and a second element (102, 102′, 102″) configured to undergo movement relative to each other corresponding to an action performed on or by the drug injection device (100, 100′, 100″), wherein the first element (130) comprises serially disposed protrusions (133), and wherein the second element (102, 102′, 102″) comprises a second element base and a deflectable transducer (170, 170′, 170″).
Nikolaj Eusebius Jakobsen, Per Einar Pontus Holm
Filed: 2 Feb 19
GRANT
Utility
Stable multi-dose compositions comprising an antibody and a preservative
17 Nov 20
The invention relates to stable, multi-dose liquid compositions containing proteins, in particular, but not exclusively stable antibodies, and to the use of said compositions in therapy, in particular for the subcutaneous delivery of said stable protein.
Henrik Parshad, Dorthe Kot Engelund
Filed: 31 Oct 17
GRANT
Utility
Drug delivery system with multipolar magnet and sensor system
17 Nov 20
A drug delivery system comprises an indicator element and a sensor system.
Nikolaj Eusebius Jakobsen, Preben Mikael Nielsen, Nikolaj Frogner Krusell, Laurits Hoejgaard Olesen
Filed: 15 Jun 20
GRANT
Utility
Shielded needle cannula
10 Nov 20
The invention relates to an injection system or a needle assembly in which a needle cannula secured to an injection device is shielded by a axially movable needle shield.
Bjoern Gullak Larsen, Christoffer Busk Stormoen, Kurt Solgaard, Thomas Olund Christensen
Filed: 11 Nov 16
GRANT
Utility
EGF(A) analogues with fatty acid substituents
3 Nov 20
The invention relates to compounds derived from the EGF(A) domain of LDL-R, in particular compounds comprising a peptide analogue of the wild-type EGF(A) (LDL-R(293-332)) sequence and at least one substituent comprising at least one fatty acid group.
Jianhe Chen, Jesper F. Lau, Janos Tibor Kodra, Birgit Wieczorek, Lars Linderoth, Henning Thoegersen, Salka Elboel Rasmussen, Patrick William Garibay
Filed: 13 Jan 17
APP
Utility
Tolerogenic DNA Vaccine
29 Oct 20
The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
Jay Chaplin, Michael Wijaranakula
Filed: 26 Apr 19
GRANT
Utility
Drug delivery device with information capture
27 Oct 20
A drug delivery device is provided comprising or adapted to receive a cartridge with an axially displaceable piston.
Andre Larsen, Henrik Riehm Soerensen
Filed: 9 Nov 16
GRANT
Utility
Anti-KIR antibodies, formulations, and uses thereof
27 Oct 20
A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided.
Peter Andreas Nicolai Reumert Wagtmann, Ivan Svendsen, Rozana Sten, Lene Hjorth Alifrangis, Rune Viig Overgaard
Filed: 20 Dec 17
APP
Utility
Syringe holder for a medical injector and method of forming a medical injector assembly
22 Oct 20
A syringe holder (200) comprising: a body (210) extending along a central longitudinal axis and adapted to receive the barrel (110) of a syringe (100), wherein the body (210) includes at least two body sections (240) disposed around the central longitudinal axis, the body sections (240, 240A, 240B) having distal ends with shoulder sections (250) adapted for being received in a circumferential gap (150) between the barrel (110) of the syringe (100) and a needle shield (120) covering a needle (130) of the syringe to retain the syringe (100) so as to prevent the syringe from moving distally (D) relative to the syringe holder (200), wherein the body (210) further comprises a plurality of expandable connector arrangements (230) each interconnecting pairs of the at least two body sections (240, 240A, 240B) so that the body sections (240, 240A, 240B) and the expandable connector arrangements (230) form a closed loop in the circumferential direction around the barrel (110) of a syringe (100) held by the body (210), wherein the expandable connector arrangements (230) are so configured that the body sections (240, 240A, 240B) are movable between a non-retaining position and a retaining position.
Lars Peter Klitmose, Ebbe Kiilerich
Filed: 24 Oct 18
APP
Utility
Drug Delivery System with Multipolar Magnet and Sensor System
22 Oct 20
A drug delivery system comprises an indicator element and a sensor system.
Laurits Hoejgaard Olesen, Henrik Bengtsson, Leif Johannsen, Keld Baden-Kristensen, John Aasted Soerensen
Filed: 3 Dec 18
GRANT
Utility
Pressure based event detection
20 Oct 20
The present invention provides a drug delivery device (1) comprising a drug delivery unit (10) comprising a dose expelling mechanism operable to expel a dose of drug from a drug reservoir (11), a cap (20) configured for dismountable mounting over a portion of the drug delivery unit (10), the cap (20) comprising a cavity (25, 26) for reception of the portion of the drug delivery unit (10), a seal (40) adapted to provide a sealing in an interface between the cap (20) and the drug delivery unit (10), a sensor system (30) configured to monitor internal pressure in the cavity (25, 26) and to register an event in response to sensing a change in the internal pressure which numerically exceeds a specified threshold level over a period of less than 5 seconds, and energy means (50) for powering the sensor system (30).
Ulrik Detlef Raedisch Poulsen
Filed: 1 Jul 16
APP
Utility
Glucose-sensitive Albumin-binding Derivatives
15 Oct 20
This invention relates to glucose-sensitive albumin-binding diboron conjugates.
Thomas Kruse, Mikael Kofoed-Hansen, Martin Werner Borchsenius Muenzel, Henning Thoegersen, Per Sauerberg, Jakob Ewald Rasmussen, Carsten Behrens, Thomas Hoeg-Jensen, Vojtech Balsanek, Zuzana Drobnakova, Ladislav Droz, Miroslav Havranek, Vladislav Kotek, Milan Stengl, Ivan Snajdr, Hana Vanova
Filed: 8 Nov 18
GRANT
Utility
Method of manufacturing one of a range of autoinjectors
13 Oct 20
A method of manufacturing one of a range of autoinjectors having cartridges (600, 600′, 600″) with different preset fill volumes, the method comprising the steps of: a) providing a front body assembly (100b, 100c, 100c′, 100c″), b) providing a cartridge (600, 600′, 600″) of given fill volume, c) providing a rear body assembly (100a) comprising a spring-driven drive ram assembly (310, 320) configured to drive the piston of a held cartridge (600, 600′, 600″), d) providing a ram spacer member (400, 400′, 400″), the ram spacer member defining a spacing geometry of length dimension (X1′, X1″, X1′″, XS′, XS″, XS′″, XR′, XR″, XR′″) selected according to the fill volume of the cartridge (600, 600′, 600″), and e) assembling a front body assembly (100b, 100c, 100c′, 100c″), the cartridge (600, 600′, 600″), the ram spacer member (400, 400′, 400″) and the rear body assembly (100a) so that the ram spacer member (400, 400′, 400″) is arranged axially between the drive ram assembly (310, 320) of the rear body assembly (100a) and the piston of a held cartridge (600, 600′, 600″).
Mads Schenstroem Stefansen, Soeren Kjellerup Hansen, Klaus Bendix
Filed: 12 Nov 15
GRANT
Utility
Method for moulding a polymeric housing for a medical injection device
13 Oct 20
The invention relates to a medical injection device having a polymeric housing or housing parts.
Ken Hansen, Imran Ghulam, Jesper Bach Noergaard, Claus Urup Gjoedesen, Asger Meng Larsen
Filed: 27 May 16
APP
Utility
Propylene Glycol-containing Peptide Formulations Which Are Optimal for Production and for Use In Injection Devices
8 Oct 20
The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated.
Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
Filed: 24 Jun 20
APP
Utility
Regimen Adherence Measure for Insulin Treatment Based on Glucose Measurements and Insulin Pen Data
1 Oct 20
Systems and methods are provided for adjusting a standing insulin medicament dosage regimen for a subject.
Henrik Bengtsson, Tinna Bjoerk Aradottir
Filed: 22 Jun 17
APP
Utility
Drug Delivery System with Multipolar Magnet and Sensor System
1 Oct 20
A drug delivery system comprises an indicator element and a sensor system.
Nikolaj Eusebius Jakobsen, Preben Mikael Nielsen, Nikolaj Frogner Krusell, Laurits Hoejgaard Olesen
Filed: 15 Jun 20
APP
Utility
Antibodies and Use Thereof
1 Oct 20
The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.
Peter Matthew Tessier, Samuel D. Stimple, Arne Staby
Filed: 31 Mar 20
APP
Utility
Amplifying Beta Cell Differentiation with Small Molecules BET (Bromodomain And Extraterminal Family Of Bromodomain-Containing Proteins) Inhibitors
1 Oct 20
The present invention provides an in vitromethod for obtaining cells of the pancreatic endocrine lineage, comprising a step of culturing pancreatic progenitor cells, wherein said pancreatic progenitor cells are in a cell culture medium comprising at least one BET inhibitor.
Lukas Huijbregts, Raphael Scharfmann, Christian Honore
Filed: 30 Jun 17